Citation Impact
Citing Papers
BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial
2013
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1
2007 StandoutNobel
Cardiovascular and Metabolic Alterations in Mice Lacking Both β1- and β2-Adrenergic Receptors
1999 StandoutNobel
Distribution of 5-HT1B, 5-HT1D and 5-HT1F receptor expression in rat trigeminal and dorsal root ganglia neurons: Relevance to the selective anti-migraine effect of triptans
2010
Functional Bowel Disorders
2006 Standout
CGRP and migraine: neurogenic inflammation revisited
2005
Calcitonin receptor‐like receptor (CLR), receptor activity‐modifying protein 1 (RAMP1), and calcitonin gene‐related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: Differences between peripheral and central CGRP receptor distribution
2008
Neurons of the Dopaminergic/Calcitonin Gene-Related Peptide A11 Cell Group Modulate Neuronal Firing in the Trigeminocervical Complex: An Electrophysiological and Immunohistochemical Study
2009
The pharmacology of headache
2000
Syndemics and the biosocial conception of health
2017 Standout
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
5-HT2 receptors modulate excitatory neurotransmission to cardiac vagal neurons within the nucleus ambiguus evoked during and after hypoxia
2009 StandoutNobel
Bowel Disorders
2016 Standout
The direct effect of carbon monoxide on K Ca channels in vascular smooth muscle cells
1997
Zolmitriptan stimulates a Ca2+-dependent K+ current in C6 glioma cells stably expressing recombinant human 5-HT1B receptors
2000
Heritability of nociception I: Responses of 11 inbred mouse strains on 12 measures of nociception
1999
Descending control of pain
2002 Standout
Direct vascular actions of hydrochlorothiazide and indapamide in isolated small vessels
1992
Anti-migraine action of triptans is preceded by transient aggravation of headache caused by activation of meningeal nociceptors
2005
The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener
2001 Standout
Potential of Substance P Antagonists as Antiemetics
2000
Antinociceptive profiles of non-peptidergic neurokinin1 and neurokinin2 receptor antagonists: a comparison to other classes of antinociceptive agent
1995
Differential effects of the 5HT1B/1D receptor agonist naratriptan on trigeminal versus spinal nociceptive responses
1998
The role of substance P in stress and anxiety responses
2006
Animal models of migraine: looking at the component parts of a complex disorder
2006
Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A−/−, 5-HT1B−/−, 5-HT2A−/−, 5-HT3A−/− and 5-HTT−/− knock-out male mice
2007 StandoutNobel
Receptor systems mediating c-fos expression within trigeminal nucleus caudalis in animal models of migraine
2001
The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles
1998
Locomotor networks are targets of modulation by sensory transient receptor potential vanilloid 1 and transient receptor potential melastatin 8 channels
2009 StandoutNobel
Trigeminocervical complex responses after lesioning dopaminergic A11 nucleus are modified by dopamine and serotonin mechanisms
2011
The 5-hydroxytryptamine1B/1D/1F receptor agonists eletriptan and naratriptan inhibit trigeminovascular input to the nucleus tractus solitarius in the cat
2003
Triptans in Migraine
2000
Stress-induced changes in gastric emptying, postprandial motility, and plasma gut hormone levels in dogs
1989
Contractile 5‐HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry
1999
Effects of PNU-109,291, a selective 5-HT1D receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalis
1999
Modulation of nocioceptive transmission with calcitonin gene-related peptide receptor antagonists in the thalamus
2010
Activation of 5‐HT1B/1D receptor in the periaqueductal gray inhibits nociception
2004
Blockade by oral or parenteral RPR 100893 (a non‐peptide NK1 receptor antagonist) of neurogenic plasma protein extravasation within guinea‐pig dura mater and conjunctiva
1994
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
Consensus Statement: Cardiovascular Safety Profile of Triptans (5‐HT 1B/1D Agonists) in the Acute Treatment of Migraine
2004
Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine
2004 Standout
G Protein-coupled Receptors
1998 StandoutNobel
The anti‐migraine 5‐HT1B/1D agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea‐pigs
2001
The Effect of pH on β2 Adrenoceptor Function
2000 StandoutNobel
No contractile effect for 5‐HT1D and 5‐HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery
2000
Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input
2003
Neuroanatomical Localization, Pharmacological Characterization and Functions of CGRP, Related Peptides and Their Receptors
1997
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Migraine — Current Understanding and Treatment
2002 Standout
Tachykinins: receptor to effector
1996
mRNA expression of 5-hydroxytryptamine 1B, 1D, and 1F receptors and their role in controlling the release of calcitonin gene–related peptide in the rat trigeminovascular system
2012
A Multigene Family Encoding a Diverse Array of Putative Pheromone Receptors in Mammals
1997 StandoutNobel
Persistent postsurgical pain: risk factors and prevention
2006 Standout
Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraine
2001
Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5‐HT1B/1D agonist
1999
Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model
2002 Standout
A review of central 5-HT receptors and their function
1999 Standout
5-HT7 receptor mRNA expression in human trigeminal ganglia
2001
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
2003 Standout
The pharmacology of CGRP-responsive receptors in cultured and transfected cells
2004
Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia
2000 Nature
The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats
1998
Development and characterisation of human 5-HT1B- or 5-HT1D-receptor specific antibodies as unique research tools
1998
Expression of the 5-HT1B receptor by subtypes of rat trigeminal ganglion cells
1999
Reversal of behavioural and electrophysiological correlates of experimental peripheral neuropathy by the NK1 receptor antagonist GR205171 in rats
1998
Transient Receptor Potential Cation Channels in Disease
2007 Standout
Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy
1999
Co-expression of Defective Luteinizing Hormone Receptor Fragments Partially Reconstitutes Ligand-induced Signal Generation
1997 StandoutNobel
CGRP and its receptors provide new insights into migraine pathophysiology
2010
Receptor Activity-modifying Proteins 2 and 3 Have Distinct Physiological Functions from Embryogenesis to Old Age
2007 StandoutNobel
Psychopharmacologic Treatment of Depression in the Medically Ill
1998
The Molecular Architecture of Odor and Pheromone Sensing in Mammals
2000 StandoutNobel
Both 5-HT1B and 5-HT1F receptors modulate c-fos expression within rat trigeminal nucleus caudalis
1999
Adenosine A1Receptor-Mediated Inhibition of Protein Kinase A-Induced Calcitonin Gene-Related Peptide Release from Rat Trigeminal Neurons
2001
Circulating Angiogenic Factors and the Risk of Preeclampsia
2004 Standout
Transmembrane Regions V and VI of the Human Luteinizing Hormone Receptor Are Required for Constitutive Activation by a Mutation in the Third Intracellular Loop
1996 StandoutNobel
Functional Diarrhea
2012
5-HT1B and 5-HT1D receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase
2001
Post-endocytic Sorting of Calcitonin Receptor-like Receptor and Receptor Activity-modifying Protein 1
2007
Neuropathic Pain Activates the Endogenous κ Opioid System in Mouse Spinal Cord and Induces Opioid Receptor Tolerance
2004 StandoutNobel
Cortico-NRM Influences on Trigeminal Neuronal Sensation
2008
Latest Advances in Understanding Preeclampsia
2005 StandoutScience
Irritable Bowel Syndrome
2015 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Design and structure of a novel Neurokinin A receptor antagonist cyclo(-Met1-Asp2-Trp3-Phe4-Dap5-Leu6-)cyclo(2β-5β)
1995
Immunohistochemical characterization of calcitonin gene-related peptide in the trigeminal system of the familial hemiplegic migraine 1 knock-in mouse
2011
Prostanoid Receptors: Structures, Properties, and Functions
1999 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
A Novel Rigid β-Turn Molecular Scaffold
1998
The Hitchhiker’s Guide to Flow Chemistry
2017 Standout
Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and Anxiety
2010 Standout
Coronary Side-Effect Potential of Current and Prospective Antimigraine Drugs
1998
Cyclization reactions of N-acryloyl-2-aminobenzaldehyde derivatives: formal total synthesis of martinellic acid
2006
Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5‐HT1B‐ and 5‐HT1F‐receptor activation
1999
G Protein-Coupled Receptors: Functional and Mechanistic Insights Through Altered Gene Expression
1998 StandoutNobel
β-Peptides: From Structure to Function
2001 Standout
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Calcitonin Gene-Related Peptide Decreases Expression of HLA-DR and CD86 by Human Dendritic Cells and Dampens Dendritic Cell-Driven T Cell-Proliferative Responses Via the Type I Calcitonin Gene-Related Peptide Receptor
2000 StandoutNobel
Involvement of neurokinin receptors in the induction but not the maintenance of mechanical allodynia in rat flexor motoneurones.
1995
Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects.
1996 StandoutNobel
The family of G‐protein‐coupled receptors
1995
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
New and Expeditious Tandem Sequence Aza-Michael/Intramolecular Nucleophilic Substitution Route to Substituted γ-Lactams: Synthesis of the Tricyclic Core of (±)-Martinellines
2008
5‐HT 1D Receptor Immunoreactivity in the Sphenopalatine Ganglion: Implications for the Efficacy of Triptans in the Treatment of Autonomic Signs Associated With Cluster Headache
2011
5-Hydroxytryptamine1B/1D and 5-Hydroxytryptamine1FReceptors Inhibit Capsaicin-Induced C-Fos Immunoreactivity Within Mouse Trigeminal Nucleus Caudalis
2002
The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
2003 Standout
Serotonin Receptors
2008
Calcitonin Gene‐Related Peptide ( CGRP ) and Migraine Current Understanding and State of Development
2013
Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRP
2014
The Pharmacology of the Ductus Arteriosus
1998
Co-localization of 5-HT1B/1D/1F receptors and glutamate in trigeminal ganglia in rats
2001
Possible sites of action of the new calcitonin gene-related peptide receptor antagonists
2010
Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2
2001 StandoutNobel
Effects of realistic office daylighting and electric lighting conditions on visual comfort, alertness and mood
2014
Neuronal Plasticity: Increasing the Gain in Pain
2000 StandoutScience
Neuropeptide Expression in the Human Trigeminal Nucleus Caudalis and in the Cervical Spinal Cord C1 and C2
2002
Wood Composite as an Energy Efficient Building Material: Guided Sunlight Transmittance and Effective Thermal Insulation
2016 Standout
The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group
2003 Standout
Colocalization of CGRP with 5‐HT1B/1D receptors and substance P in trigeminal ganglion neurons in rats
2001
Sodium-Potassium-Chloride Cotransport
2000 Standout
Formal total synthesis of (±)-martinellic acid
2005
Migraine Therapy
1997
Works of J. Longmore being referenced
A comparison of the contractile effects of 5‐hydroxytryptamine, sumatriptan and MK‐462 on human coronary artery in vitro.
1995
The effects of GR127935, a putative 5-HT1D receptor antagonist, on brain 5-HT metabolism, extracellular 5-HTT concentration and behaviour in the guinea pig
1995
Pharmacological specificity of novel, synthetic, cyclic peptides as antagonists at tachykinin receptors
1991
Antinociceptive activity of NK1 receptor antagonists: non‐specific effects of racemic RP67580
1993
Comparison of the vasoconstrictor effects of the selective 5‐HT1D‐receptor agonist L‐775,606 with the mixed 5‐HT1B/1D‐receptor agonist sumatriptan and 5‐HT in human isolated coronary artery
2000
Bradykinin antagonists: new opportunities
2000
An Immunocytochemical Investigation of Human Trigeminal Nucleus Caudalis: Cgrp, Substance P and 5-Ht1D-Receptor Immunoreactivities Are Expressed by Trigeminal Sensory Fibres
2002
Differences in the effects of ketanserin and GR127935 on 5-HT-receptor mediated responses in rabbit saphenous vein and guinea-pig jugular vein
1995
The Potassium Channel Openers: A New Class of Vasorelaxants
1990
Differences between the effects of cromakalim and nifedipine on agonist‐induced responses in rabbit aorta
1991
Characterization of a Fluorescent Substance P Analog
1994
Effects of two truncated forms of human calcitonin-gene related peptide: implications for receptor classification
1994
Effects of cromakalim, RP49356, diazoxide, glibenclamide and galanin in rat portal vein
1990
Effects of a controlled-release formulation of trazodone on psychomotor and autonomic functions in healthy volunteers: Comparison with trazodone (conventional formulation), amitriptyline and placebo
1988
5-HT1D receptor agonists and human coronary artery reactivity in vitro: crossover comparisons of 5-HT and sumatriptan with rizatriptan and L-741,519
1996
Neurokinin-receptor antagonists: pharmacological tools and therapeutic drugs
1997
Differential Distribution of 5Ht1D-and 5HT1B-Immunoreactivity within the Human Trigemino-Cerebrovascular System: Implications for the Discovery of New Antimigraine Drugs
1997
Comparison of the vasoconstrictor properties of the 5-HT1D-receptor agonists rizatriptan (MK-462) and sumatriptan in human isolated coronary artery: outcome of two independent studies using different experimental protocols.
1997
Psychological stress and the passage of a standard meal through the stomach and small intestine in man
1983
5‐HT1D receptor agonists and human coronary artery reactivity in vitro: crossover comparisons of 5‐HT and sumatriptan with rizatriptan and L‐741,519
1996
Glare from windows: current views of the problem
1982
Differences in the effects of NK1‐receptor antagonists, (±)‐CP 96,345 and CP 99,994, on agonist‐induced responses in guinea‐pig trachea
1994
The chemical evolution of N,N-dimethyl-2-[5-(1,2,4-triazol-4-yl)-1H-indol-3-yl]ethylamine (L-741,604) and analogues: Potent and selective agonists for 5-HT1D receptors
1996
Neurokinin-receptor antagonists: pharmacological tools and therapeutic drugs
1997